Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Myron Czuczman"'
Autor:
Carla Casulo, Armando Santoro, Guillaume Cartron, Kiyoshi Ando, Javier Munoz, Steven Le Gouill, Koji Izutsu, Simon Rule, Pieternella Lugtenburg, Jia Ruan, Luca Arcaini, Marie‐Laure Casadebaig, Brian Fox, Nurgul Kilavuz, Nils Rettby, Justine Dell'Aringa, Lilia Taningco, Richard Delarue, Myron Czuczman, Thomas Witzig
Publikováno v:
Cancer Reports, Vol 6, Iss 1, Pp n/a-n/a (2023)
Abstract Background Studies suggest that immune checkpoint inhibitors may represent a promising strategy for boosting immune responses and improving the antitumor activity of standard therapies in patients with relapsed/refractory hematologic maligna
Externí odkaz:
https://doaj.org/article/53982eb6c7094c0dbc546b6a65f550a0
Autor:
Wyndham H. Wilson, Sin-Ho Jung, Pierluigi Porcu, David Hurd, Jeffrey Johnson, S. Eric Martin, Myron Czuczman, Raymond Lai, Jonathan Said, Amy Chadburn, Dan Jones, Kieron Dunleavy, George Canellos, Andrew D. Zelenetz, Bruce D. Cheson, Eric D. Hsi
Publikováno v:
Haematologica, Vol 97, Iss 5 (2012)
Background A phase II trial of dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin and rituximab (DA-EPOCH-R) from the National Cancer Institute showed promising activity in untreated diffuse large B-cell lymphoma. The Can
Externí odkaz:
https://doaj.org/article/e1ff211289dc492bbcad1a39e5398f16
Autor:
Mitchell S. Cairo, Myron Czuczman, Matthew Barth, Carmella van de Ven, Janet Ayello, Ashlin Yahr, Jessica Hochberg, Yaya Chu
Supplementary Fig.S1: Anti-CD20 CAR enhances NK92 cells in-vitro cytolytic activity against CD20+ B-NHL cells by retroviral transduction. (A) Schematic representation of the anti-CD20 chimeric receptor in an RD114-pseudotyped retroviral vector. LTR i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a96d8595e03a1e1f5f257064f279ca81
https://doi.org/10.1158/2326-6066.22538390.v1
https://doi.org/10.1158/2326-6066.22538390.v1
Autor:
Mitchell S. Cairo, Myron Czuczman, Matthew Barth, Carmella van de Ven, Janet Ayello, Ashlin Yahr, Jessica Hochberg, Yaya Chu
Supplementary Methods, Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::495b73cf926fe0ec35f82c1d6ac635e5
https://doi.org/10.1158/2326-6066.22538369
https://doi.org/10.1158/2326-6066.22538369
Autor:
Mitchell S. Cairo, Myron Czuczman, Matthew Barth, Carmella van de Ven, Janet Ayello, Ashlin Yahr, Jessica Hochberg, Yaya Chu
The prognosis is very dismal for patients with relapsed CD20+ B-cell non-Hodgkin lymphoma (B-NHL). Facilitating the development of alternative novel therapeutic strategies is required to improve outcomes in patients with recurrent/refractory CD20+ B-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aad51f16f88c23e08467ec1793779411
https://doi.org/10.1158/2326-6066.c.6548762.v1
https://doi.org/10.1158/2326-6066.c.6548762.v1
Autor:
Francine M. Foss, Youn H. Kim, H. Miles Miles Prince, Timothy M. Kuzel, Costas K. Yannakou, Chean Eng Ooi, Dongyuan Xing, Nicholas Sauter, Preeti Singh, Myron Czuczman, Madeleine Duvic
Publikováno v:
Blood. 140:1491-1492
Autor:
H. Miles Miles Prince, Larisa J Geskin, Oleg E Akilov, Timothy M. Kuzel, Christiane Querfeld, Chean Eng Ooi, Dongyuan Xing, Nicholas Sauter, Preeti Singh, Myron Czuczman, Francine M. Foss
Publikováno v:
Blood. 140:6577-6578
Autor:
Kento Homma, Kazuki Hashimoto, Nikolay Bazhanov, Matt Angel, Alan Lader, Myron Czuczman, Michael Matthay, Perenlei Enkhbaatar
Publikováno v:
Critical Care Medicine. 50:734-734
Autor:
Theresa, Hahn, Steven N, Wolff, Myron, Czuczman, Richard I, Fisher, Hillard M, Lazarus, Philip L, McCarthy, Julie, Vose, Lisa, Warren, Richard, Watt
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 9(10)
Autor:
Ping-Chiao Tsai, Bangia Naveen, Scott Olejniczak, Francisco Hernandez-Ilizaliturri, Myron Czuczman
Publikováno v:
The Journal of Immunology. 184:88.18-88.18
Rituximab(R) resistance is associated with low CD20 expression in relapsed/refractory (r/r) lymphomas. Studies had shown a direct correlation between CD20 levels and R-induced complement cell lysis. CD20 up-regulation by IL-4 serves as a useful tool